Allison W. Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Allison W. Peng has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Michael Joseph Blaha
Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD (M.J.B.).
4 shared publications - Fatima Rodriguez
Stanford University School of Medicine
3 shared publications - Matthew H. Levine
Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA
3 shared publications - Seth Shay Martin
Johns Hopkins University School of Medicine
3 shared publications - Alexander C. Razavi
Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA (A.C.R.).
2 shared publications Edgar R. Miller
The Johns Hopkins University School of Medicine, The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland, USA
2 shared publications
Latest Publications
- 5 November 2026
- Published by Elsevier in JACC: Cardiovascular Imaging
Beyond the Coronary Artery Calcium Score
- 5 November 2026
- Published by Elsevier in JACC: Cardiovascular Imaging
Beyond the Coronary Artery Calcium Score
- 2 June 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1552-1562
From identification to implementation: A narrative review of strategies to close the implementation gap in patients with familial hypercholesterolemia
- 2 June 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1552-1562
From identification to implementation: A narrative review of strategies to close the implementation gap in patients with familial hypercholesterolemia
- 27 January 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (4) , 290-293
Prevalence of Apolipoprotein B and LDL Cholesterol Discordance: Insights From the VLDbL and NHANES
- 27 January 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (4) , 290-293
Prevalence of Apolipoprotein B and LDL Cholesterol Discordance: Insights From the VLDbL and NHANES
- Open Access
- 15 May 2024
- Published by Elsevier in JACC: Advances
- Vol. 3 (7) , 100963
Sociodemographic Differences Among Patients Receiving Coronary Artery Calcium Imaging vs Nongated Chest Computed Tomography Imaging
- 15 May 2024
- Published by Elsevier in JACC: Advances
- Vol. 3 (7) , 100963
Open AccessSociodemographic Differences Among Patients Receiving Coronary Artery Calcium Imaging vs Nongated Chest Computed Tomography Imaging
- Open Access
- 16 April 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (8) , e031444
Temporal Trends in Cardiovascular Disease Prevalence Among Asian American Subgroups
Background: Asian and multiracial individuals represent the 2 fastest growing racial and ethnic groups in the United States, yet most prior studies report Asian American and Native Hawaiian or Other Pacific Islander as a single racial group, with limited data on cardiovascular disease (CVD) prevalence among subgroups. We sought to evaluate temporal trends in CVD burden among disaggregated Asian subgroups. Methods and Results: Patients with CVD based on International Classification of Diseases, Ninth Revision and Tenth Revision ( ICD‐9 and ICD‐10 ) coding who received care from a mixed‐payer health care organization in California between 2008 and 2018 were classified into self‐identified racial and ethnic subgroups (non‐Hispanic White [NHW], Asian Indian, Chinese, Filipino, Japanese, Korean, Native Hawaiian or Other Pacific Islander, and multiracial groups). Adjusted trends in CVD prevalence over time by subgroup were compared using logistic regression. Among 3 494 071 patient‐years, prevalence of CVD increased faster among all subgroups except Japanese and Native Hawaiian or Other Pacific Islander patients ( P P P P P <0.05 for each, reference: NHW). Conclusions: The increasing prevalence of CVD among disaggregated Asian, Native Hawaiian or Other Pacific Islander, and multiracial subgroups over time highlights the importance of tailored approaches to addressing CVD in these diverse subpopulations.
- 16 April 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (8) , e031444
Open AccessTemporal Trends in Cardiovascular Disease Prevalence Among Asian American Subgroups
Background: Asian and multiracial individuals represent the 2 fastest growing racial and ethnic groups in the United States, yet most prior studies report Asian American and Native Hawaiian or Other Pacific Islander as a single racial group, with limited data on cardiovascular disease (CVD) prevalence among subgroups. We sought to evaluate temporal trends in CVD burden among disaggregated Asian subgroups. Methods and Results: Patients with CVD based on International Classification of Diseases, Ninth Revision and Tenth Revision ( ICD‐9 and ICD‐10 ) coding who received care from a mixed‐payer health care organization in California between 2008 and 2018 were classified into self‐identified racial and ethnic subgroups (non‐Hispanic White [NHW], Asian Indian, Chinese, Filipino, Japanese, Korean, Native Hawaiian or Other Pacific Islander, and multiracial groups). Adjusted trends in CVD prevalence over time by subgroup were compared using logistic regression. Among 3 494 071 patient‐years, prevalence of CVD increased faster among all subgroups except Japanese and Native Hawaiian or Other Pacific Islander patients ( P P P P P <0.05 for each, reference: NHW). Conclusions: The increasing prevalence of CVD among disaggregated Asian, Native Hawaiian or Other Pacific Islander, and multiracial subgroups over time highlights the importance of tailored approaches to addressing CVD in these diverse subpopulations.
- Open Access
- 30 March 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-6
Contemporary attitudes and beliefs on coronary artery calcium from social media using artificial intelligence
Coronary artery calcium (CAC) is a powerful tool to refine atherosclerotic cardiovascular disease (ASCVD) risk assessment. Despite its growing interest, contemporary public attitudes around CAC are not well-described in literature and have important implications for shared decision-making around cardiovascular prevention. We used an artificial intelligence (AI) pipeline consisting of a semi-supervised natural language processing model and unsupervised machine learning techniques to analyze 5,606 CAC-related discussions on Reddit. A total of 91 discussion topics were identified and were classified into 14 overarching thematic groups. These included the strong impact of CAC on therapeutic decision-making, ongoing non-evidence-based use of CAC testing, and the patient perceived downsides of CAC testing (e.g., radiation risk). Sentiment analysis also revealed that most discussions had a neutral (49.5%) or negative (48.4%) sentiment. The results of this study demonstrate the potential of an AI-based approach to analyze large, publicly available social media data to generate insights into public perceptions about CAC, which may help guide strategies to improve shared decision-making around ASCVD management and public health interventions.
- 30 March 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-6
Open AccessContemporary attitudes and beliefs on coronary artery calcium from social media using artificial intelligence
Coronary artery calcium (CAC) is a powerful tool to refine atherosclerotic cardiovascular disease (ASCVD) risk assessment. Despite its growing interest, contemporary public attitudes around CAC are not well-described in literature and have important implications for shared decision-making around cardiovascular prevention. We used an artificial intelligence (AI) pipeline consisting of a semi-supervised natural language processing model and unsupervised machine learning techniques to analyze 5,606 CAC-related discussions on Reddit. A total of 91 discussion topics were identified and were classified into 14 overarching thematic groups. These included the strong impact of CAC on therapeutic decision-making, ongoing non-evidence-based use of CAC testing, and the patient perceived downsides of CAC testing (e.g., radiation risk). Sentiment analysis also revealed that most discussions had a neutral (49.5%) or negative (48.4%) sentiment. The results of this study demonstrate the potential of an AI-based approach to analyze large, publicly available social media data to generate insights into public perceptions about CAC, which may help guide strategies to improve shared decision-making around ASCVD management and public health interventions.
- 25 October 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (17) , E275-E276
Response by Peng et al to Letter Regarding Article, “Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non–Cardiovascular Disease Outcomes, and Mortality: Results From MESA”
- 25 October 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (17) , E275-E276
Response by Peng et al to Letter Regarding Article, “Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non–Cardiovascular Disease Outcomes, and Mortality: Results From MESA”
- 1 January 2020
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 13 (1) , 83-93
Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000
- 1 January 2020
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 13 (1) , 83-93
Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000